Skip to content
⌘KStart free
AI InfrastructureDefenseQuantumAll studies →

ENGN US Equity

enGene Therapeutics Inc.
Nasdaq+ CompareTear sheet →
Health Care · Biological Products, (No Diagnostic Substances) · CIK 1980845 · FY ends Oct 31
$1.78
+0.01 (+0.56%)
USD · as of 2026-08-21 · marketstack